Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Change in Account Payables: 2018-2024

Historic Change in Account Payables for Black Diamond Therapeutics (BDTX) over the last 7 years, with Dec 2024 value amounting to $1.7 million.

  • Black Diamond Therapeutics' Change in Account Payables fell 51.20% to -$694,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.6 million, marking a year-over-year increase of 46.77%. This contributed to the annual value of $1.7 million for FY2024, which is 181.91% up from last year.
  • Per Black Diamond Therapeutics' latest filing, its Change in Account Payables stood at $1.7 million for FY2024, which was up 181.91% from $597,000 recorded in FY2023.
  • Black Diamond Therapeutics' Change in Account Payables' 5-year high stood at $1.7 million during FY2024, with a 5-year trough of -$2.2 million in FY2022.
  • For the 3-year period, Black Diamond Therapeutics' Change in Account Payables averaged around $16,667, with its median value being $597,000 (2023).
  • In the last 5 years, Black Diamond Therapeutics' Change in Account Payables plummeted by 242.13% in 2022 and then skyrocketed by 181.91% in 2024.
  • Black Diamond Therapeutics' Change in Account Payables (Yearly) stood at $1.1 million in 2020, then spiked by 46.77% to $1.6 million in 2021, then slumped by 242.13% to -$2.2 million in 2022, then spiked by 126.77% to $597,000 in 2023, then surged by 181.91% to $1.7 million in 2024.